Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism

Hormone and Metabolic Research

Volumn 44, Issue 7, 2012, Pages 527-532

  Willenberg, H S ^a,b   Vonend, O ^a   Schott, M ^a   Gao, X ^a   Blondin, D ^a   Saleh, A ^a   Rump, L C ^a   Scherbaum, W A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

adrenal; aldosterone; fludrocortisones; hypertension

Indexed keywords

ALDOSTERONE; CITRATE POTASSIUM; FLUDROCORTISONE; FUROSEMIDE; RENIN; SODIUM CHLORIDE;

ADRENAL CORTEX ADENOMA; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE VARIABILITY; CHILL; COMPARATIVE STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENDOCRINE FUNCTION TEST; ESSENTIAL HYPERTENSION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FLUDROCORTISONE SUPPRESSION TEST; HEADACHE; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RECEIVER OPERATING CHARACTERISTIC; SALINE INFUSION TEST; SENSITIVITY AND SPECIFICITY;

ALDOSTERONE; DIAGNOSTIC TECHNIQUES AND PROCEDURES; FEMALE; FLUDROCORTISONE; HUMANS; HYPERALDOSTERONISM; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; ROC CURVE; SODIUM CHLORIDE;

EID: 84861976428     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1314786     Document Type: Article

References (27)

1. Ehrhart-Bornstein M, Hinson J P, Bornstein S R, Scherbaum W A, Vinson G P. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev: 1998; 19 101 143 (Pubitemid 29114288)
2. Willenberg H S, Schinner S, Ansurudeen I. New mechanisms to control aldosterone synthesis. Horm Metab Res: 2008; 40 435 441
3. Gomez-Sanchez C E, Rossi G P, Fallo F, Mannelli M. Progress in primary aldosteronism: present challenges and perspectives. Horm Metab Res: 2010; 42 374 381
4. Tomaschitz A, Pilz S. Aldosterone to renin ratio - a reliable screening tool for primary aldosteronism? Horm Metab Res: 2010; 42 382 391
5. Mazzuco T L, Grunenwald S, Lampron A, Bourdeau I, Lacroix A. Aberrant hormone receptors in primary aldosteronism. Horm Metab Res: 2010; 42 416 423
6. Funder J W, Carey R M, Fardella C, Gomez-Sanchez C E, Mantero F, Stowasser M, Young W F Jr, Montori V M. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab: 2008; 93 3266 3281
7. Giacchetti G, Ronconi V, Lucarelli G, Boscaro M, Mantero F. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens: 2006; 24 737 745
8. Rossi G P, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Semplicini A, Agabiti-Rosei E, Pessina A C, Mantero F. PAPY Study Investigators Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens: 2007; 25 1433 1442 (Pubitemid 46918831)
9. Gordon R D. Mineralocorticoid hypertension. Lancet: 1994; 23; 344 240 243 (Pubitemid 24229015)
10. Mulatero P, Milan A, Fallo F, Regolisti G, Pizzolo F, Fardella C, Mosso L, Marafetti L, Veglio F, Maccario M. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab: 2006; 91 2618 2623 (Pubitemid 44024627)
11. Stowasser M, Gordon R D, Gunasekera T G, Cowley D C, Ward G, Archibald C, Smithers B M. High rate of detection of primary aldosteronism, including surgically treatable forms, after non-selective' screening of hypertensive patients. J Hypertens: 2003; 21 2149 2157 (Pubitemid 38296877)
12. Fardella C E, Mosso L, Gómez-Sánchez C, Cortés P, Soto J, Gómez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab: 2000; 85 1863 1867 (Pubitemid 32269290)
13. Milliez P, Girerd X, Plouin P F, Blacher J, Safar M E, Mourad J J. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol: 2005; 45 1243 1248 (Pubitemid 40523144)
14. Born-Frontsberg E, Reincke M, Rump L C, Hahner S, Diederich S, Lorenz R, Allolio B, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Endres S, Quinkler M. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metab: 2009; 94 1125 1130
15. Born-Frontsberg E, Reincke M, Beuschlein F, Quinkler M. Participants of German Conn's Registry. Tumor size of Conn's adenoma and comorbidities. Horm Metab Res: 2009; 41 785 788
16. Quinkler M, Born-Frontsberg E, Fourkiotis V G. Comorbidities in primary aldosteronism. Horm Metab Res: 2010; 42 429 434
17. Rossi G P, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M, Matterello M J, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Pessina A C, Mantero F. Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension: 2006; 48 232 238 (Pubitemid 44309817)
18. Sechi L A, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi G L, Catena C. Long-term renal outcomes in patients with primary aldosteronism. JAMA: 2006; 295 2638 2645 (Pubitemid 43882339)
19. Reincke M, Rump L C, Quinkler M, Hahner S, Diederich S, Lorenz R, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Meisinger C, Holle R, Endres S. Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab: 2009; 94 869 875
20. Mulatero P, Stowasser M, Loh K C, Fardella C E, Gordon R D, Mosso L, Gomez-Sanchez C E, Veglio F, Young W F Jr. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab: 2004; 89 1045 1050 (Pubitemid 38368386)
21. Rossi G P, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello M J, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina A C, Mantero F. A prospective study of the prevalence of primary aldosteronism in 1 125 hypertensive patients. J Am Coll Cardiol: 2006; 48 2293 2300 (Pubitemid 44873058)
22. Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, Papadopoulos N, Vogiatzis K, Zamboulis C. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet: 2008; 371 1921 1926 (Pubitemid 351778191)
23. Connell J M, Fraser R, MacKenzie S, Davies E. Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension? Hypertension: 2003; 41 993 999 (Pubitemid 36548592)
24. Willenberg H S, Kolentini C, Quinkler M, Cupisti K, Krausch M, Schott M, Scherbaum W A. The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism. Eur J Clin Invest: 2009; 39 43 50
25. Tomaschitz A, Maerz W, Pilz S, Ritz E, Scharnagl H, Renner W, Boehm B O, Fahrleitner-Pammer A, Weihrauch G, Dobnig H. Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range. J Am Coll Cardiol: 2010; 55 2171 2180
26. Choi M, Scholl U I, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men C J, Lolis E, Wisgerhof M V, Geller D S, Mane S, Hellman P, Westin G, Åkerström G, Wang W, Carling T, Lifton R P. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science: 2011; 331 768 772
27. Mulatero P, Monticone S, Bertello C, Mengozzi G, Tizzani D, Iannaccone A, Veglio F. Conrmatory tests in the diagnosis of primary aldosteronism. Horm Metab Res: 2010; 42 406 410